• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终生饮酒对非酒精性脂肪性肝病组织学严重程度的影响。

Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.

机构信息

Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

Liver Int. 2014 Jan;34(1):129-35. doi: 10.1111/liv.12230. Epub 2013 Jun 28.

DOI:10.1111/liv.12230
PMID:23809459
Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is defined based on recent alcohol consumption; however, remote or lifetime alcohol consumption is not taken into account. It is not known whether lifetime alcohol consumption contributes to the severity of disease in patients with NAFLD. To determine the effect of lifetime alcohol consumption on the histological severity in patients with NAFLD.

PATIENTS & METHODS: Adults >18 years of age with presumed NAFLD and alcohol consumption <40 g/week were enrolled. Lifetime alcohol consumption was determined using a questionnaire. Patients with a history of long-term alcohol abuse or dependence were excluded. A liver biopsy was reviewed by a single pathologist in a blinded fashion. Demographic, clinical and histological findings were compared in those who had regular alcohol consumption and those who did not.

RESULTS

A total of 77 patients had fatty liver on biopsy. Fifty-two patients had a history of regular alcohol consumption. The median lifetime cumulative alcohol intake was 24 gram-years. On multivariable analysis, increasing age (OR 1.07, 95% CI 1.01-1.14) was associated with severe liver disease, whereas alcohol consumption of ≥24 gram-years was associated with less severe disease (OR 0.26, 95% CI 0.07-0.97, P = 0.04). Patients who continued to consume alcohol or had been abstinent for ≤1 year had less severe disease.

CONCLUSION

Some degree of regular alcohol consumption over the course of a lifetime compared to minimal intake appears to have a protective effect on the histological severity of liver disease among patients with strictly defined NAFLD.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)是基于近期饮酒情况定义的;然而,并未考虑到既往或终生的饮酒情况。目前尚不清楚终生饮酒是否会加重 NAFLD 患者的疾病严重程度。本研究旨在确定终生饮酒对 NAFLD 患者组织学严重程度的影响。

患者与方法

入组年龄>18 岁且推测患有 NAFLD 且每周酒精摄入量<40 g 的患者。采用问卷确定终生饮酒量。排除有长期酒精滥用或依赖史的患者。对所有患者均行肝脏活检,由同一位病理学家进行盲法评估。比较有规律饮酒史和无规律饮酒史患者的人口统计学、临床和组织学特征。

结果

共有 77 例患者的肝脏活检提示存在脂肪变性。52 例患者有规律饮酒史。终生累积饮酒量中位数为 24 克年。多变量分析显示,年龄增长(OR 1.07,95%CI 1.01-1.14)与严重肝病相关,而饮酒量≥24 克年与较轻的肝病相关(OR 0.26,95%CI 0.07-0.97,P=0.04)。继续饮酒或戒酒时间≤1 年的患者肝脏疾病较轻。

结论

与最低饮酒量相比,终生有一定程度的规律饮酒史似乎对严格定义的 NAFLD 患者的肝脏疾病组织学严重程度具有保护作用。

相似文献

1
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.终生饮酒对非酒精性脂肪性肝病组织学严重程度的影响。
Liver Int. 2014 Jan;34(1):129-35. doi: 10.1111/liv.12230. Epub 2013 Jun 28.
2
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者一生低至中度饮酒与肝纤维化进展程度较低有关。
Scand J Gastroenterol. 2017 Feb;52(2):159-165. doi: 10.1080/00365521.2016.1239759. Epub 2016 Oct 6.
3
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).适量饮酒与非酒精性脂肪性肝病(NAFLD)患者中肝脂肪变性的发生率降低有关。
J Hepatol. 2012 Aug;57(2):384-91. doi: 10.1016/j.jhep.2012.03.024. Epub 2012 Apr 17.
4
Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.饮酒类型和模式与非酒精性脂肪性肝病患者的肝纤维化相关。
Am J Gastroenterol. 2018 Oct;113(10):1484-1493. doi: 10.1038/s41395-018-0133-5. Epub 2018 Jun 14.
5
Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.饮酒与非酒精性脂肪性肝病的肝纤维化进展相关。
Scand J Gastroenterol. 2009;44(3):366-74. doi: 10.1080/00365520802555991.
6
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).多囊卵巢综合征(PCOS)患者的非酒精性脂肪性肝炎(NASH)。
Scand J Gastroenterol. 2011 Apr;46(4):479-84. doi: 10.3109/00365521.2010.539251. Epub 2010 Nov 30.
7
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.阿尔巴尼亚超重儿童的非酒精性脂肪性肝病和非酒精性脂肪性肝炎
Minerva Pediatr. 2014 Feb;66(1):23-30.
8
[Clinical and histological features of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的临床和组织学特征
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6.
9
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.香港中文人群中质子磁共振波谱和瞬时弹性成像技术检测非酒精性脂肪性肝病及肝纤维化的流行率:一项基于人群的研究。
Gut. 2012 Mar;61(3):409-15. doi: 10.1136/gutjnl-2011-300342. Epub 2011 Aug 16.
10
Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.非酒精性脂肪性肝炎和非酒精性脂肪性肝病的外科治疗。
Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

引用本文的文献

1
Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD.在经活检证实为MAFLD的患者中,轻度至中度饮酒和糖尿病与肝纤维化有关。
Front Pharmacol. 2024 Jul 31;15:1437479. doi: 10.3389/fphar.2024.1437479. eCollection 2024.
2
Response to semaglutide of non-drinker subjects with type 2 diabetes.2型糖尿病非饮酒者对司美格鲁肽的反应。
Diabetol Metab Syndr. 2024 May 17;16(1):103. doi: 10.1186/s13098-024-01344-6.
3
Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease.
低剂量饮酒对慢性肝病的影响。
Nutrients. 2024 Feb 23;16(5):613. doi: 10.3390/nu16050613.
4
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.代谢综合征与饮酒之间的相互作用会增加患肝病的风险。
United European Gastroenterol J. 2024 Mar;12(2):168-176. doi: 10.1002/ueg2.12524. Epub 2024 Feb 21.
5
Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease.在患有代谢功能障碍相关脂肪性肝病的非重度饮酒者中,单纯饮用酒类和鸡尾酒与肝纤维化风险增加有关。
Alcohol Clin Exp Res (Hoboken). 2024 Jan;48(1):88-97. doi: 10.1111/acer.15220. Epub 2023 Nov 29.
6
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.代谢功能障碍相关脂肪性肝病增加心血管疾病发病风险:一项全国性队列研究
EClinicalMedicine. 2023 Oct 28;65:102292. doi: 10.1016/j.eclinm.2023.102292. eCollection 2023 Nov.
7
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity.代谢功能障碍相关脂肪性肝病的批判性评价:两面性现代性的启示。
Clin Mol Hepatol. 2023 Oct;29(4):831-843. doi: 10.3350/cmh.2023.0277. Epub 2023 Aug 25.
8
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.酒精性肝病与非酒精性脂肪性肝病的交集。
Nat Rev Gastroenterol Hepatol. 2023 Dec;20(12):764-783. doi: 10.1038/s41575-023-00822-y. Epub 2023 Aug 15.
9
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.脂肪肝疾病、代谢与酒精相互作用:全面综述。
Int J Mol Sci. 2023 Apr 24;24(9):7791. doi: 10.3390/ijms24097791.
10
Nutritional and Lifestyle Therapy for NAFLD in People with HIV.营养和生活方式疗法治疗 HIV 感染者的非酒精性脂肪性肝病。
Nutrients. 2023 Apr 20;15(8):1990. doi: 10.3390/nu15081990.